Search results
Flood of Fake Science Forces Multiple Journal Closures
The Wall Street Journal· 11 minutes agoFake studies have flooded the publishers of top scientific journals leading to thousands of...
Museum of Science to unveil major renovation in mid-2026 - The Boston Globe
The Boston Globe· 2 hours agoBloomberg Philanthropies is the charitable foundation of Michael Bloomberg, the businessman, former...
Kodiak Sciences dosing subjects in Phase III trial of diabetic retinopathy drug
Clinical Trials Arena via Yahoo Finance· 40 minutes agoUS-based biotechnology company Kodiak Sciences has dosed the first subjects with diabetic...
DoST opens P5-M green bio-hydrogen-to-energy lab - BusinessWorld Online
BusinessWorld· 14 minutes agoTHE DEPARTMENT of Science and Technology (DoST) announced on Tuesday that it opened a Green Bio-Hydrogen to Energy Laboratory in Cagayan de Oro to address the need for sustainable ...
NASA selects proposals for new line of Earth science missions
SpaceNews· 54 minutes agoNASA has picked four Earth science mission proposals for further study while separately selecting a...
Alimera Sciences: Q1 Earnings Snapshot
San Francisco Chronicle· 34 minutes agoALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Alimera Sciences Inc. (ALIM) on Tuesday...
Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 5 hours agoBellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report) was the target of a large...
Revised master plan unveiled for science campus at Manchester Airport
World Construction Network via Yahoo Finance· 2 hours agoA revised master plan has been unveiled for developing a science, innovation, and manufacturing...
Caris Life Sciences to Showcase Extensive Research Highlighting the Clinical Value of Comprehensive...
FOX 5 San Diego· 2 hours agoCaris Life Sciences® (Caris), the leading next-generation AI TechBio company and precision medicine pioneer, today announced that the company and collaborators from the biopharma ...
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer...
FOX 23 News Albany· 13 hours agoKodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing...